These recommendations were developed at a consensus meeting of clinicians and interested parties on 5 January 2016. Therapies that are NICE approved are presented in bold and those that are NICE unapproved are italicised.

The prices of the different regimens vary considerably. Clinicians should use the most cost effective treatment option taking account of the individual patient's requirements.